CAMRYN FLANAGAN: Open Payments
NPI 1295580108 · JEFFERSON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,088 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $673 · 2025 $1,088
Food & beverage: $888Education: $200
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 7 | $376 |
| Kite Pharma, Inc. | 4 | $322 |
| Janssen Biotech, Inc. | 2 | $201 |
| Astellas Pharma US Inc | 1 | $100 |
| Janssen Scientific Affairs, LLC | 1 | $72 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Yescarta, Niktimvo, RYBREVANT, TALVEY, ERLEADA, JAKAFI.
Industry payments across LA — which companies pay providers there.
